NASDAQ:SSKN - STRATA Skin Sciences Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $2.61 -0.02 (-0.76 %) (As of 11/16/2018 09:36 AM ET)Previous Close$2.63Today's Range$2.61 - $2.6152-Week Range$1.09 - $3.88Volume200 shsAverage Volume115,554 shsMarket Capitalization$79.95 millionP/E Ratio1.32Dividend YieldN/ABeta0.82 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email STRATA Skin Sciences, Inc., a medical technology company, focuses on the therapeutic and aesthetic dermatology market. The company operates through three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment, and Dermatology Imaging. Its products include XTRAC laser and VTRAC excimer lamp systems used for the treatment of psoriasis, vitiligo, and other skin conditions; the STRATAPEN MicroSystems, a micropigmentation device; and Nordlys, a multi-technology aesthetic laser device for treating vascular and pigmented lesions. STRATA Skin Sciences, Inc. was founded in 1989 and is based in Horsham, Pennsylvania. Receive SSKN News and Ratings via Email Sign-up to receive the latest news and ratings for SSKN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SSKN Previous Symbol CUSIPN/A Webwww.strataskinsciences.com Phone215-619-3200 Debt Debt-to-Equity Ratio0.22 Current Ratio4.77 Quick Ratio4.20 Price-To-Earnings Trailing P/E Ratio1.32 Forward P/E Ratio-13.05 P/E GrowthN/A Sales & Book Value Annual Sales$31.45 million Price / Sales2.48 Cash Flow$0.4745 per share Price / Cash5.50 Book Value$5.46 per share Price / Book0.48 Profitability EPS (Most Recent Fiscal Year)$1.97 Net Income$-18,830,000.00 Net Margins-18.33% Return on Equity-20.38% Return on Assets-12.69% Miscellaneous Employees98 Outstanding Shares29,940,000Market Cap$79.95 million OptionableNot Optionable STRATA Skin Sciences (NASDAQ:SSKN) Frequently Asked Questions What is STRATA Skin Sciences' stock symbol? STRATA Skin Sciences trades on the NASDAQ under the ticker symbol "SSKN." When did STRATA Skin Sciences' stock split? How did STRATA Skin Sciences' stock split work? STRATA Skin Sciences's stock reverse split on the morning of Thursday, July 10th 2014. The 1-10 reverse split was announced on Thursday, July 3rd 2014. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 9th 2014. An investor that had 100 shares of STRATA Skin Sciences stock prior to the reverse split would have 10 shares after the split. How were STRATA Skin Sciences' earnings last quarter? STRATA Skin Sciences Inc (NASDAQ:SSKN) issued its earnings results on Tuesday, November, 13th. The medical device company reported ($0.01) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.04) by $0.03. The medical device company had revenue of $7.89 million for the quarter, compared to analyst estimates of $7.64 million. STRATA Skin Sciences had a negative net margin of 18.33% and a negative return on equity of 20.38%. View STRATA Skin Sciences' Earnings History. When is STRATA Skin Sciences' next earnings date? STRATA Skin Sciences is scheduled to release their next quarterly earnings announcement on Monday, April 1st 2019. View Earnings Estimates for STRATA Skin Sciences. What price target have analysts set for SSKN? 2 analysts have issued twelve-month price objectives for STRATA Skin Sciences' stock. Their predictions range from $5.00 to $5.00. On average, they expect STRATA Skin Sciences' stock price to reach $5.00 in the next year. This suggests a possible upside of 90.1% from the stock's current price. View Analyst Price Targets for STRATA Skin Sciences. What is the consensus analysts' recommendation for STRATA Skin Sciences? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STRATA Skin Sciences in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for STRATA Skin Sciences. What are Wall Street analysts saying about STRATA Skin Sciences stock? Here are some recent quotes from research analysts about STRATA Skin Sciences stock: 1. According to Zacks Investment Research, "Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. " (11/16/2018) 2. HC Wainwright analysts commented, "Valuation and risks to price target achievement. We maintain our Buy rating with a price target of $5. Our price target is based on our clinical net present value (NPV) model, which is currently driven by the company’s lead asset, XTRAC, and project upside from: (1) increase in patients treated for lead indication psoriasis; and (2) increasing traction for XTRAC in its other approved indications, vitiligo and eczema/ atopic dermatitis." (10/10/2018) Has STRATA Skin Sciences been receiving favorable news coverage? Media stories about SSKN stock have trended somewhat positive recently, InfoTrie Sentiment reports. The research group ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. STRATA Skin Sciences earned a daily sentiment score of 0.9 on InfoTrie's scale. They also assigned media stories about the medical device company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the near term. Are investors shorting STRATA Skin Sciences? STRATA Skin Sciences saw a decline in short interest during the month of October. As of October 31st, there was short interest totalling 360,954 shares, a decline of 46.2% from the October 15th total of 670,668 shares. Based on an average daily volume of 153,027 shares, the short-interest ratio is presently 2.4 days. Approximately 2.0% of the shares of the stock are short sold. View STRATA Skin Sciences' Current Options Chain. Who are some of STRATA Skin Sciences' key competitors? Some companies that are related to STRATA Skin Sciences include MiMedx Group (MDXG), Nuvectra (NVTR), Cytosorbents (CTSO), Liquidia Technologies (LQDA), SeaSpine (SPNE), Iradimed (IRMD), Westaim (WEDXF), GenMark Diagnostics (GNMK), Pulse Biosciences (PLSE), T2 Biosystems (TTOO), RenovaCare (RCAR), Alphatec (ATEC), Endologix (ELGX), RA Medical Systems (RMED) and Sensus Healthcare (SRTS). Who are STRATA Skin Sciences' key executives? STRATA Skin Sciences' management team includes the folowing people: Dr. Dolev Rafaeli, CEO & Director (Age 54)Mr. Matthew C. Hill, VP & CFO (Age 49)Mr. Jay Sturm, Corp. Counsel & Corp. Sec. (Age 62)Keith Simeone, VP of SalesDr. Darrell S. Rigel M.D., Ms, Faad, Chief Medical Advisor (Age 67) Who are STRATA Skin Sciences' major shareholders? STRATA Skin Sciences' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (2.49%), EAM Investors LLC (0.78%), Dimensional Fund Advisors LP (0.22%), Alambic Investment Management L.P. (0.12%) and Macquarie Group Ltd. (0.10%). Company insiders that own STRATA Skin Sciences stock include Frank J Mccaney, James L Coyne, Luann Via, Matthew C Hill and Samuel E Navarro. View Institutional Ownership Trends for STRATA Skin Sciences. Which institutional investors are selling STRATA Skin Sciences stock? SSKN stock was sold by a variety of institutional investors in the last quarter, including Macquarie Group Ltd.. View Insider Buying and Selling for STRATA Skin Sciences. Which institutional investors are buying STRATA Skin Sciences stock? SSKN stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, EAM Investors LLC, Alambic Investment Management L.P. and Dimensional Fund Advisors LP. Company insiders that have bought STRATA Skin Sciences stock in the last two years include Frank J Mccaney, James L Coyne, Luann Via, Matthew C Hill and Samuel E Navarro. View Insider Buying and Selling for STRATA Skin Sciences. How do I buy shares of STRATA Skin Sciences? Shares of SSKN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is STRATA Skin Sciences' stock price today? One share of SSKN stock can currently be purchased for approximately $2.63. How big of a company is STRATA Skin Sciences? STRATA Skin Sciences has a market capitalization of $79.95 million and generates $31.45 million in revenue each year. The medical device company earns $-18,830,000.00 in net income (profit) each year or $1.97 on an earnings per share basis. STRATA Skin Sciences employs 98 workers across the globe. What is STRATA Skin Sciences' official website? The official website for STRATA Skin Sciences is http://www.strataskinsciences.com. How can I contact STRATA Skin Sciences? STRATA Skin Sciences' mailing address is 100 LAKESIDE DRIVE SUITE 100, HORSHAM PA, 19044. The medical device company can be reached via phone at 215-619-3200 or via email at [email protected] MarketBeat Community Rating for STRATA Skin Sciences (NASDAQ SSKN)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 144 (Vote Outperform)Underperform Votes: 127 (Vote Underperform)Total Votes: 271MarketBeat's community ratings are surveys of what our community members think about STRATA Skin Sciences and other stocks. Vote "Outperform" if you believe SSKN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SSKN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 11/16/2018 by MarketBeat.com StaffFeatured Article: What is a balanced fund?